Researchers discover new way to measure if a person is pre-diabetic
The University of Hawai'i Cancer Center discovery could warn patients years in advance allowing for a lifestyle change.
Diabetes
Knowledge gap over effects of some diabetes drugs
A gap in scientific knowledge about a family of drugs that are used to treat Type 2 diabetes has been highlighted in a new study.
News • Research
Link between diabetes and bone health
Diabetes, which now affects almost 30 million Americans, can cause serious health complications, including heart disease, blindness, kidney failure and lower-extremity amputations. A lesser-known but equally grave complication is the effect of diabetes on bone health.“Clinical trials have revealed a startling elevation in fracture risk in diabetic patients,” says Liyun Wang, associate…
Common diabetes drug could prevent hemorrhage and fatal blood loss
A new study, published today in the British Journal of Pharmacology, by scientists from Royal Holloway, University of London, St George's, University of London and University of Surrey have identified that a drug related to commonly used diabetes treatments provides protection against terminal blood loss.
News • AACC News
New tests to diagnose and monitor diabetes
Researchers have successfully tested two new potential methods for diagnosing and monitoring diabetes in its standard and gestational forms. These findings, presented at the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta, may lead to easier, timelier, and more affordable ways of identifying and treating this chronic disease.
News • Diabetics and elderly
Ultrasound accelerates skin healing
Researchers from the University of Sheffield’s Department of Biomedical Science discovered the ultrasound transmits a vibration through the skin and wakes up cells in wounds helping to stimulate and accelerate the healing process.
News • Genetics
Blood pressure regulation by a stress-sensitive gatekeeper
Researchers at the RIKEN Brain Science Institute have uncovered a new mechanism for the regulation of blood pressure. Published in Molecular Cell, the study links events at the single-cell level to a system-level effect, showing that blood pressure can drop dramatically if the protein ERAP1 is released from cells and enters the blood stream.
Article • Gentle intervention
Endoscopy jumps the boundaries
‘Health insurers should keep a tighter rein on the quality of endoscopic interventions because, mostly, they represent a gentler alternative to surgery,’ asserts international expert Horst Neuhaus, during an EH interview. Report: Daniela Zimmermann/Juliane Dannert
Article • Diabetes
THE epidemic of the 21st century
According to the International Diabetes Federation (IDF) in recent decades the development of diabetes mellitus (DM) warrants the conclusion that this is among the most important global epidemics. Report: Walter Depner
News • Technology
Diabetes: Smart insulin patch could replace painful injections
Painful insulin injections could become a thing of the past for the millions of Americans who suffer from diabetes, thanks to a new invention from researchers at the University of North Carolina and NC State, who have created a “smart insulin patch” that can detect increases in blood sugar levels and secrete doses of insulin into the bloodstream whenever needed.
Article • Diabetes II
Manufacturers declare support
This year’s German medical diagnostics manufacturers association (Verband der deutschen Diagnostica-Hersteller = VDGH) congress, focused on diabetes. The panel discussion that closed the evening session revealed unanimous support for the adoption of a German national diabetes plan. Report: Bettina Döbereiner
Article • Diabetes I
Diabetology news
The focus of the 2015 Diabetes Congress held in Berlin this May was ‘Personalised diabetes treatment: innovative – individual – sustained’. EH reports on points aired during the supporting press briefing. Report: Bettina Döbereiner
News • Proteomics International Laboratories Ltd.
Predictive test for diagnosis of diabetic kidney disease
Life sciences company Proteomics International Laboratories (ASX: PIQ) is pleased to announce that it has produced and validated a predictive test for the diagnosis of diabetic kidney disease (DKD). The test, called PromarkerD, is the world's first proteomics-derived predictive (prognostic) test for the diagnosis of DKD, and represents a global breakthrough in the diagnosis and treatment of the…
High-tech textiles – more than just clothes
High-tech textiles must fulfill a number of functions and meet many requirements. That is why the Fraunhofer Institute for Silicate Research ISC dedicated some major developing work to this most intriguing research area. The result can now be seen at Techtextil trade show in Frankfurt from 4 to 7 May. On display will be novel textile-integrated sensors, a unique multifunctional coating system for…
Sponsored • POCT
This market will boom
The turnover in POCT diagnostics will continue to increase substantially according to participants in an ‘In Vitro Diagnostic Products’ meeting held in Toronto, Canada last October. Sponsored by the German Institute for Standardisation, the event included participation by the DIN Standards Committee Medicine (NAMed; NA 063) and the Working Committee on Point of Care Testing (POCT) (NA…
Princeton Engineers Develop a Non-invasive Blood Glucose Test that Uses Imaging Technology
Glucose testing is both a headache and an opportunity for clinical laboratories here in the United States and across the globe. It is a headache because many point-of-care and patient self-test glucose devices in wide use today lack the reliability of glucose testing performed in medical laboratories that use sophisticated diagnostic instruments.
Bayer to divest Interventional device business for $415 million
Bayer HealthCare has entered into a definitive agreement to sell its Interventional device business to Boston Scientific for $415 million (about EUR 300 million), including fees for transitional services. The sale will include the AngioJet (thrombectomy) and Jetstream (atherectomy) systems, and the Fetch2 Aspiration Catheter used in cardiology, radiology and peripheral vascular procedures.
News • Diabetes
The value of fermentation
Raise your intake of low-fat fermented dairy products, including all yoghurt varieties and some low-fat cheeses, and you could lower your risk of new-onset type 2 diabetes by 28%, according to new research published in Diabetologia (the journal of the European Association for the Study of Diabetes).
Printable IVDs put diagnostics in a patient’s pocket
Using electrically conductive, ink-like materials, a Swedish consortium has created a fully functional prototype for a self-monitoring blood glucose (SMBG) test that could be disruptive for in vitro diagnostics.
Walking to work cuts risk of diabetes and high blood pressure
People who walk to work are around 40 per cent less likely to have diabetes as those who drive, according to a new study
"Excellence across Borders" fosters practical diabetes management
Bayer HealthCare supports local projects under the "Excellence across Borders" program in order to improve care of people with diabetes. Among the projects is a Diabetic School Awareness Program in the Kingdom of Saudi Arabia, which is planned to start in autumn this year.
Point of care testing
Demand is increasing for point of care (POC) diagnostic testing, particularly for tests that help foster clinical decision-making within 30 minutes or less.
Promise for controlling'blood-brain barrier'
Working with mice, Johns Hopkins researchers have shed light on the activity of a protein pair found in cells that form the walls of blood vessels in the brain and retina, experiments that could lead to therapeutic control of the blood-brain barrier and of blood vessel growth in the eye.
Indispensible in many medical specialties – the seca mBCA
Until now doctors had to use complex methods to get an accurate picture of a patient's body composition. The seca mBCA simplifies that complicated technology and after less than 20 seconds, it delivers all medically relevant data.
EKF Diagnostics launches a new low cost POC HbA1c analyser
EKF Diagnostics, a worldwide manufacturer of point-of-care (POC) in-vitro diagnostic devices, has announced the European launch of its Quo-Lab POC HbA1c analyser.